Syndax Pharmaceuticals (SNDX) Earnings Date, Estimates & Call Transcripts $19.89 0.00 (0.00%) (As of 10/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 7EstimatedActual EPS (Aug. 1) -$0.80 Beat By $0.11 Consensus EPS (Aug. 1) -$0.91 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Get Syndax Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for SNDX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSNDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNDX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressThis algorithmic pattern has won 72% of the timeOver the last three decades, Roger Scott has traded dozens of market patterns… Some were phenomenal…. Others were a disappointment… But since 2020 one pattern that has outshined them all… It’s shown the ability to work in the best of times and the worst of times. During the bear market of 2022, it went 18 for 20… It does not thrive on price action but rather on algorithmic activity. When the pattern flashes he knows with a high degree of certainty, that the algorithms are buying shares… This has allowed him to capture meaningful wins more than 7 out of every 10 attempts. Sign up by following this link. Syndax Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($1.00)($0.91)($0.96)Q2 20242($0.96)($0.95)($0.96)Q3 20242($1.05)($0.95)($1.00)Q4 20242($1.22)($0.96)($1.09)FY 20248($4.23)($3.77)($4.00)SNDX Earnings Date and InformationSyndax Pharmaceuticals last announced its earnings data on August 1st, 2024. The reported ($0.80) EPS for the quarter, beating the consensus estimate of ($0.91) by $0.11. The firm had revenue of $3.50 million for the quarter. Its revenue for the quarter was up 3499999990.0% compared to the same quarter last year. Syndax Pharmaceuticals has generated ($3.38) earnings per share over the last year (($3.38) diluted earnings per share). Earnings for Syndax Pharmaceuticals are expected to grow in the coming year, from ($3.66) to ($3.35) per share. Syndax Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off prior year's report dates.Read More Syndax Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/7/2024(Estimated)------- 8/1/2024Q2 2024($0.91)($0.80)+$0.11($0.80)-$3.50 million 5/8/2024Q1 2024($0.96)($0.85)+$0.11($0.85)-- 2/27/2024Q4 2023($0.99)($1.00)($0.01)($1.00)-- 11/2/2023Q3 2023($0.80)($0.73)+$0.07($0.73)-- 8/3/2023Q2 2023($0.73)($0.64)+$0.09($0.64)-- 5/8/2023Q1 2023($0.61)($0.59)+$0.02($0.59)-- Get the Latest News and Ratings for SNDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/2023Q4 2022($0.64)($0.62)+$0.02($0.62)-- 11/3/2022Q3 2022($0.65)($0.58)+$0.07($0.58)-- 8/8/2022Q2 2022($0.65)($0.62)+$0.03($0.62)-- 5/9/2022Q1 2022($0.63)($0.63)-($0.63)-- 3/1/2022Q4 2021($0.68)$1.81+$2.49$1.81-$126.58 million 11/15/2021Q3 2021($0.64)($0.40)+$0.24($0.40)-$12.38 million 8/9/2021Q2 2021($0.74)($0.44)+$0.30($0.44)$0.50 million$0.38 million 5/11/2021Q1 2021($0.63)($0.54)+$0.09($0.54)$0.50 million$0.38 million 3/7/2021Q4 2020($0.49)($0.44)+$0.05($0.44)-$0.38 million 11/2/2020Q3 2020($0.42)($0.46)($0.04)($0.46)-$0.38 million 8/6/2020Q2 2020($0.47)($0.42)+$0.05($0.42)-$0.38 million 5/7/2020Q1($0.51)($0.56)($0.05)($0.56)$0.38 million$0.38 million 3/3/2020Q4 2019($0.46)($0.44)+$0.02($0.44)$0.38 million$0.38 million 11/7/2019Q3($0.48)($0.41)+$0.07($0.41)$0.38 million$0.38 million Syndax Pharmaceuticals Earnings - Frequently Asked Questions When is Syndax Pharmaceuticals's earnings date? Syndax Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates. Learn more on SNDX's earnings history. Did Syndax Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Syndax Pharmaceuticals (NASDAQ:SNDX) reported ($0.80) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.91) by $0.11. Learn more on analysts' earnings estimate vs. SNDX's actual earnings. How can I listen to Syndax Pharmaceuticals's earnings conference call? The conference call for Syndax Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Syndax Pharmaceuticals's conference call transcript? The conference call transcript for Syndax Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Syndax Pharmaceuticals generate each year? Syndax Pharmaceuticals (NASDAQ:SNDX) has a recorded annual revenue of $139.71 million. How much profit does Syndax Pharmaceuticals generate each year? Syndax Pharmaceuticals (NASDAQ:SNDX) has a recorded net income of -$209.36 million. SNDX has generated -$3.38 earnings per share over the last four quarters. What is Syndax Pharmaceuticals's EPS forecast for next year? Syndax Pharmaceuticals's earnings are expected to grow from ($3.66) per share to ($3.35) per share in the next year. More Earnings Resources from MarketBeat Related Companies: AMPH Earnings Results ENTA Earnings Results CYTK Earnings Results BPMC Earnings Results KRYS Earnings Results ADMA Earnings Results BHVN Earnings Results OGN Earnings Results BBIO Earnings Results RNA Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles: Taiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth? This page (NASDAQ:SNDX) was last updated on 10/18/2024 by MarketBeat.com Staff From Our PartnersDon’t Buy Another Stock Until Reading This…Buying stocks in today's market is a gamble… Unless you're using the right proven strategy! During my up...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.